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Conclusions: Monaco VMARS was comparable to LGK SRS in 
terms of PGI and PCI for targets larger than 1 cc. Beam 
delivery time for Monaco VMARS was significantly shorter 
than that for LGK SRS. Monaco VMARS has a potential to be 
an alternative option for treatment of multiple brain 
metastases.  
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Purpose/Objective: There is a growing trend towards 
algorithms which improve the efficiency and consistency of 
treatment plan generation. One such implementation is the 
Varian RapidPlan™ knowledge-based treatment planning 
module which uses a library of clinically acceptable 
treatment plans to generate a model that can predict 
optimum DVH optimisation objectives on a patient-specific 
basis. The aim of this study was to evaluate the suitability of 
using RapidPlan to create acceptable VMAT plans for cervical 
cancer cases against those that were previously considered 
clinically acceptable. 
Materials and Methods: The RapidPlan model was generated, 
according to manufacturer guidance, based on 37 clinical 
patients treated for Cervical Cancer using VMAT. The model 
included all patients with varying clinical and physiological 
indications, i.e. all intact uteri and post-hysterectomy cases 
were included, as well as those where the inguinal nodes 
were clinically included. The two different prescription levels 
used in our centre were included; 45Gy/25 fractions and 
50.4Gy/28 fractions. The model required minor adjustments 
after generation; to fix the PTV optimisation priorities and 
the normal tissue objective. VMAT plans were independently 
re-generated for 5 different cases using RapidPlan who had 
not been included in the model configuration. The cases 
included post-hysterectomy (45Gy/25#, n=2) and intact-uteri 
(50.4Gy/28#, n=3) cases. A single optimisation was used to 
assess the quality of the model. VMAT plans consisted of one 
isocentre and two coplanar 360° arcs. Doses to the rectum, 
bowel, bladder, femoral heads and bone marrow were 
evaluated. The 95% conformity index (CI95%) was calculated 
for the PTVs, as well as D98% and D2%; representing the near-
min and near-max doses respectively. The total number of 
monitor units required for the two techniques was compared. 
Results: Table 1 shows a summary of the average parameter 
values (± s.d.) for the PTV, OARs, and MU; p-values are based 
on the Wilcoxon signed-rank test. In all cases, RapidPlan 
indicated on average comparable or better sparing of the 
OARs, with the most significant difference being for the 
femoral heads, bladder D1cm3 and bone marrow V10Gy. PTV 
coverage was more conformal for RapidPlan as indicated by 
the CI95% being on average 0.09 lower than the original plans 
(p=0.01). The D98% (p=0.19) and D2% (p<0.01) were marginally 
better for the original plans. The MUs for RapidPlan were on 
average 57 MU higher than the original plans (p=0.14), which 
is due to increased modulation as indicated by the better 
dose conformity.  
 
 
Conclusions: The RapidPlan system, after configuring a 
Cervix Cancer VMAT model, was able to produce treatment 
plans, in a single optimisation, that overall had comparable 
sparing and better conformity than the original clinically 
acceptable plans. The system allows for better consistency 
and efficiency in the treatment planning process. 
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Purpose/Objective: Cone beam computed tomography 
(CBCT) is less adept at guiding irradiation of soft tissue 
targets. To effectively localize soft tissue targets, we 
developed an integrated bioluminescence tomography 
(BLT)/CBCT system for the small animal radiation research 
platform (SARRP). We demonstrate BLT-guided radiotherapy 
and validate targeting accuracy in vivo. The resolving power 
of the optical system to distinguish two light sources is also 
evaluated in this study.  
Materials and Methods: The on-board BLT system was 
designed to dock onto the SARRP for the optical image 
acquisition and detach before the delivery of radiation. It 
comprises of a mirror-filter -camera assembly with a light-
tight enclosure. The mirror system directs bioluminescence 
emitted from the subject to the CCD camera, and filters are 
used to acquire the multispectral bioluminescence images. 
The BLT reconstruction has been shown to be more accurate 
with the multispectral data than that with single wavelength. 
SARRP CBCT was utilized to provide anatomical information 
for mesh generation for BLT reconstruction. To validate BLT 
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targeting accuracy, a cylindrical luminescence light source, 
0.9mm in diameter × 2mm in length, was placed into the 
abdomen of a mouse carcass. The center of mass (CoM) of 
the source was reconstructed and used to guide radiation 
delivery. The accuracy of the BLT-guided irradiation was 
validated with films placed on the beam exit side of the 
animal, and compared with the results using CBCT guidance. 
The resolving power of our BLT algorithm to distinguish two 
luminescence sources was studied in a simulation study 
involving two sources of (1, 3, 6) mm in diameter at 
separations of (3, 6, 9) mm and depths of (3, 4, 6, 9, and 12) 
mm respectively. The grouped CoM of the reconstructed 
double sources was evaluated and compared to the true CoM. 
The phantom and in vivo study with 2 sources is on-going.  
Results: For the in vivo experiments with an embedded 
luminescence source, our on-board BLT was able to recover 
the CoM of the source at 1mm accuracy. The difference 
between the BLT- and CBCT-guided targeting positions 
measured with films was consistent with the source location 
offsets revealed in the BLT and CBCT images and was less 
than 1 mm. Our 2-source simulations show that for all source 
sizes, depths and separations considered, the reconstructed 
grouped COM agreed with the true COM to within 1mm. For 
the case of two 3mm diameter sources, mimicking a typical 
tumor model, our results show that the two sources can be 
resolved for most cases but not for the smallest separation of 
3mm at deep depths of 9 and 12mm.  
Conclusions: The targeting accuracy and resolving power of 
our BLT guided system is presented in this work. The 
integrated BLT/CBCT guided on-board SARRP system shows 
potential for accurate localization of soft tissue targets for 
irradiation and would be most important for the increasingly 
important small, non-palpable, orthotropic or spontaneous 
tumor models.  
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Purpose/Objective: PET/MR imaging may be highly valuable 
for radiotherapy (RT) treatment planning. To enable RT- 
specific patient positioning in PET/MR imaging we propose a 
hardware solution which we evaluated towards MR image 
quality. 
Materials and Methods: The prototype of the RT positioning 
hardware (Qfix, Avondale, PA, USA) consists of a flat table 
overlay and dedicated coil holders that allow for MR imaging 
of the head and neck (HN) region on an integrated PET/MR 
system (Biograph mMR, Siemens) by using flexible body 
matrix radiofrequency (RF) coils. An in-house designed 
overlay add-on allows for the fixation of RT masks for HN. All 
hardware components are MR compatible and optimized 
towards low 511keV-photon attenuation.  
Evaluation of the RT hardware setup in terms of clinical 
feasibility, PET attenuation properties and MR image quality 
was based on PET/MR examinations of HN cancer patients 
(N=8) and MR-only scans of healthy volunteers (N=3). Each 
time, two scans were performed: (A) using the RT setup with 
a pair of 6-channel flexible body matrix RF coils, (B) a 
reference scan without the RT setup using a standard 16-
channel HN coil. 
In total, n=5 T2w TIRM, n=6 T1w MPRAGE, and n=4 diffusion-
weighted (DW) MR images (b = 0, 500 and 1000 s/mm2) were 
acquired. For evaluation of MR image quality ROIs were 
placed in the RT dataset (A) and transferred to the reference 
dataset (B) by rigid registration. In the anatomical images 
ROIs were placed in gray and white matter, whereas in the 
DW images ROIs were set in thalamus, pons, cerebellum and 
ventricles. Within the ROIs, the mean signal, signal-to-noise 
ratio (SNR), contrast and contrast-to-noise ratio (CNR) were 
determined. 
For PET image reconstruction, previously derived CT-based 
attenuation maps were used for attenuation correction of all 
hardware devices. 
Results: The mean percentage deviation of SNR, CNR, mean 
signal and contrast for images of scan (A) compared to (B) is 
presented in Table 1. Anatomical MR images showed a mean 
loss in SNR of up to 33%, whereas CNR loss was up to 37%. In 
DW images approximately 28% loss in SNR was observed for 
all three b-value images. The ADC was reduced by 3 ± 4% 
(mean ± stdev), whereas the mean standard deviation of the 
ADC across the ROIs in the RT setup map was higher by 13%. 
Preliminary analyses further indicate the feasibility of 
adequate PET attenuation correction of the RT setup. 
Conclusions: The presented PET/MR hardware solution 
enables for RT specific patient positioning of HN cancer 
patients in clinical practice. Imaging with RT setup resulted 
in lower SNRs and CNRs. However, preliminary visual 
assessment by an experienced radiologist indicates that 
image quality is still adequate for diagnostics and tumor 
volume delineation. 
The use of the RT setup yielded higher standard deviations in 
ADC maps which will further be assessed with regard to RT 
applicability. In a next step, the influence of the RT setup on 
geometrical accuracy will be analyzed.  
By enabling for imaging in RT treatment position the 
hardware solution will in the future facilitate functional 
PET/MR data to be integrated into RT treatment planning. 
 
 
 
